Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brigida Barberio

Showing results (71-80 of 136) with videos related to

Pageof 14
Sort By:
Expert Review of Gastroenterology & Hepatology|September 22, 2021
An update of pharmacology, efficacy, and safety of vonoprazan in acid-related disordersVincenzo Savarino, Luca Antonioli, Matteo Fornai, et al.
Clinical and Experimental Gastroenterology|April 30, 2020
Vonoprazan Fumarate for the Treatment of Gastric Ulcers: A Short Review on Emerging DataElisa Marabotto, Sebastiano Ziola, Vincenzo Savarino, et al.
Clinical and Translational Gastroenterology|July 18, 2020
Infliximab Originator, Infliximab Biosimilar, and Adalimumab Are More Effective in Crohn's Disease Than Ulcerative Colitis: A Real-Life Cohort StudyBrigida Barberio, Fabiana Zingone, Renata D'Incà, et al.
Journal of Clinical Medicine|July 2, 2020
Clinical and Psychological Impact of COVID-19 Infection in Adult Patients with Eosinophilic Gastrointestinal Disorders during the SARS-CoV-2 OutbreakEdoardo Vincenzo Savarino, Paola Iovino, Antonella Santonicola, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 2, 2022
Treatment Trends for Eosinophilic Esophagitis and the Other Eosinophilic Gastrointestinal Diseases: Systematic Review of Clinical TrialsPierfrancesco Visaggi, Matteo Ghisa, Brigida Barberio, et al.
Journal of Clinical Gastroenterology|September 24, 2021
Serum Levels of PCSK9 Are Increased in Patients With Active Ulcerative Colitis Representing a Potential Biomarker of Disease Activity: A Cross-sectional StudyCarla Marinelli, Fabiana Zingone, Maria Giovanna Lupo, et al.
Expert Review of Gastroenterology & Hepatology|July 5, 2025
Could modulating the esophageal microbiome be the answer for eosinophilic esophagitis treatment?Sonia Facchin, Erica Bonazzi, Antonietta Tomasulo, et al.
Clinical Pharmacology and Therapeutics|March 5, 2026
Concomitant 5-Aminosalicylic Acid Does Not Affect the Efficacy of Janus Kinase Inhibitors in Ulcerative ColitisAntonio Tursi, Andrea Pasta, Walter Elisei, et al.
Expert Review of Gastroenterology & Hepatology|April 18, 2025
Recent developments in managing luminal microbial ecology in patients with inflammatory bowel disease: from evidence to microbiome-based diagnostic and personalized therapyErica Bonazzi, Caterina De Barba, Greta Lorenzon, et al.
Minerva Gastroenterology|September 2, 2025
The microbiota-brain connection in neurological diseases: the ubiquitous short-chain fatty acidsLuisa Bertin, Erica Bonazzi, Sonia Facchin, et al.
Pageof 14

Showing results (71-80 of 136) with videos related to

Sort By:
Pageof 14
Expert Review of Gastroenterology & Hepatology|September 22, 2021
An update of pharmacology, efficacy, and safety of vonoprazan in acid-related disordersVincenzo Savarino, Luca Antonioli, Matteo Fornai, et al.
Clinical and Experimental Gastroenterology|April 30, 2020
Vonoprazan Fumarate for the Treatment of Gastric Ulcers: A Short Review on Emerging DataElisa Marabotto, Sebastiano Ziola, Vincenzo Savarino, et al.
Clinical and Translational Gastroenterology|July 18, 2020
Infliximab Originator, Infliximab Biosimilar, and Adalimumab Are More Effective in Crohn's Disease Than Ulcerative Colitis: A Real-Life Cohort StudyBrigida Barberio, Fabiana Zingone, Renata D'Incà, et al.
Journal of Clinical Medicine|July 2, 2020
Clinical and Psychological Impact of COVID-19 Infection in Adult Patients with Eosinophilic Gastrointestinal Disorders during the SARS-CoV-2 OutbreakEdoardo Vincenzo Savarino, Paola Iovino, Antonella Santonicola, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 2, 2022
Treatment Trends for Eosinophilic Esophagitis and the Other Eosinophilic Gastrointestinal Diseases: Systematic Review of Clinical TrialsPierfrancesco Visaggi, Matteo Ghisa, Brigida Barberio, et al.
Journal of Clinical Gastroenterology|September 24, 2021
Serum Levels of PCSK9 Are Increased in Patients With Active Ulcerative Colitis Representing a Potential Biomarker of Disease Activity: A Cross-sectional StudyCarla Marinelli, Fabiana Zingone, Maria Giovanna Lupo, et al.
Expert Review of Gastroenterology & Hepatology|July 5, 2025
Could modulating the esophageal microbiome be the answer for eosinophilic esophagitis treatment?Sonia Facchin, Erica Bonazzi, Antonietta Tomasulo, et al.
Clinical Pharmacology and Therapeutics|March 5, 2026
Concomitant 5-Aminosalicylic Acid Does Not Affect the Efficacy of Janus Kinase Inhibitors in Ulcerative ColitisAntonio Tursi, Andrea Pasta, Walter Elisei, et al.
Expert Review of Gastroenterology & Hepatology|April 18, 2025
Recent developments in managing luminal microbial ecology in patients with inflammatory bowel disease: from evidence to microbiome-based diagnostic and personalized therapyErica Bonazzi, Caterina De Barba, Greta Lorenzon, et al.
Minerva Gastroenterology|September 2, 2025
The microbiota-brain connection in neurological diseases: the ubiquitous short-chain fatty acidsLuisa Bertin, Erica Bonazzi, Sonia Facchin, et al.
Pageof 14